VAXIMM to Attend International Scientific and Industry Events

BASEL, Switzerland and MANNHEIM, Germany, May 27 (Korea Bizwire) — VAXIMM AG, a Swiss/German biotech company focused on developing an oral plug and play DNA vaccination technology to stimulate patients’ cytotoxic T-cells targeting a wide range of cancer-related antigens, announced today that the Company will attend several international scientific and industry events in the coming [...]